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ABSTRACT
Objective: To evaluate the association between white
matter lesion (WML) volume, silent infarcts and
restless legs syndrome (RLS) in a population-based
study of elderly individuals.
Design: Cross-sectional study.
Setting: Population-based Three-City study.
Participants: 1035 individuals from the Dijon, France,
centre of the Three-City study who had available
information on volume of WMLs from MRIs and who
answered questions about the prevalence of RLS.
Primary outcome measure: Prevalence of RLS.
Results: WML volume was measured using an
automated tissue segmentation method. Logistic
regression was used to evaluate adjusted associations
between tertiles of WML volume and RLS and between
silent infarcts and RLS. 218 individuals (21.1%) were
determined to have RLS. Compared with those in the
first tertile of WML volume, individuals in the second
tertile (OR=1.09; 95% CI 0.75 to 1.60) or third tertile
(OR=1.17; 95% CI 0.79 to 1.74) did not have an
increased prevalence of RLS. We also did not observe
associations between the volume of deep or
periventricular WML and RLS; nor did we observe an
association between silent brain infarcts and RLS
(OR=0.74; 95% CI 0.40 to 1.39). These findings were
not modified by age or gender.
Conclusions: Higher volume of WML and the
presence of silent infarcts were not associated with an
increased prevalence of RLS in this population-based
cohort of elderly individuals.
INTRODUCTION
Restless legs syndrome (RLS) is a neuro-
logical disorder that originates in the moto-
neurons of the brain and is characterised by
an urge to move the legs and unpleasant leg
sensations. Population-based studies using
the minimal diagnostic criteria from the
International Restless Legs Syndrome Study
Group
12have found the prevalence of RLS
ranges from 6% to 12% with women being
affected twice as often as men.
3 In addition,
the prevalence of RLS increases with age.
3
While the causes of RLS are unknown, some
studies have suggested that dysfunction of
the dopaminergic system may contribute to
disease development. However, neuroima-
ging studies have not shown any primary
neurodegeneration of dopaminergic neurons
in the substantia nigra.
4 A large genetics con-
sortium study has found some genetic var-
iants that may be associated with the
development of RLS.
5
Several studies have found associations
between cardiovascular risk factors including
smoking,
6–10 diabetes,
791 1hypercholerolae-
mia,
91 0exercise,
9 body mass index
691 21 3
and hypertension
71 41 5and RLS. These asso-
ciations have led to the hypothesis that RLS
may be a risk factor for cardiovascular
disease. However, evidence for an association
between RLS and incident cardiovascular
disease is mixed.
691 11 5 –20 One recent longi-
tudinal study did not ﬁnd evidence of an
association between RLS and incident cardio-
vascular disease
21 while others found an asso-
ciation between RLS and coronary heart
disease
22 and mortality.
23 Several possible
biological mechanisms have been proposed
to explain why RLS may be associated with
high blood pressure, heart disease and
Strengths and limitations of this study
▪ Strengths include the population-based setting
with available brain imaging and the size of the
cohort.
▪ Additionally, we performed a standardised
assessment of restless legs syndrome using cri-
teria from the International Restless Legs Study
Group and used an automated measurement
procedure to quantify and localise white matter
lesions.
▪ Limitations to this study include its cross-
sectional design, lack of information on kidney
disease or iron deficiency for participants, and
self-reported information on RLS.
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Open Access Researchstroke. RLS is associated with sympathetic hyperactivity
which may lead to daytime hypertension which itself is a
risk factor for heart disease and stroke. Alternatively,
even if the sympathetic hyperactivity does not lead to
daytime hypertension, it may impact atherosclerotic
plaque formation and rupture which could lead to heart
disease and stroke. Other comorbidities associated with
RLS may also be risk factors for heart disease and
stroke.
24 In addition to its association with cardiovascular
risk factors, RLS is also associated with migraine in men
and women.
25 26
Given the association of RLS with several vascular risk
factors as well as with migraine, we were interested to
know if white matter lesions (WMLs), which are also
strongly related to vascular risk factors, including
migraine, and cardiovascular disease, were associated
with RLS. Using a population-based cohort of elderly
individuals residing in France, we examined the cross-
sectional association between WML volume and RLS
prevalence.
METHODS
The Three-City (3C) is a longitudinal cohort study enrol-
ling participants living in three French cities (Bordeaux,
Dijon and Montpellier) designed to estimate the risk of
dementia and cognitive impairment attributable to vas-
cular risk factors.
27 The present analysis only uses data
from participants living in Dijon because data on RLS
were only collected in that city. Each participant signed
an informed consent statement.
To be eligible for the 3C study, the participant needed
to live in Dijon, be registered on the electoral rolls in
1999, be 65 years or older and not be institutionalised. A
total of 4931 individuals were recruited at the Dijon site
between 1999 and 2001. For the MRI substudy, all parti-
cipants recruited from the Dijon centre who were
<80 years of age and enrolled between June 1999 and
September 2000 were eligible to participate. Of those eli-
gible, 2285 (82%) participants agreed to participate in
the MRI study, but only 1924 scans could be performed
at baseline due to ﬁnancial constraints.
The process of obtaining the MRI information has
been described in detail elsewhere.
28 29 In brief, MRIs
were obtained using a 1.5 T Magnetom (Siemens,
Erlangen, Germany). A three-dimensional (3D) high-
resolution T1-weighted brain volume was obtained using
a 3D inversion recovery fast spoiled-gradient echo
sequence. T2-weighted and proton density
(PD)-weighted brain volumes were acquired using a 2-D
dual spin echo sequence with two echo times. Each par-
ticipant data set (T1, T2, PD) was reconstructed and
visually checked for major artefacts before being stored.
A fully automated image processing software was used
to detect, measure and localise WMLs. The process has
been described in detail previously.
28 29 Based on the
morphological parameters (centre of mass coordinates,
Euclidian distance to the ventricular system, principal
axes dimension), each WML was labelled as being either
periventricular if the distance to the ventricular system
was <10 mm or deep otherwise. Total volume of periven-
tricular and deep WMLs were estimated by summing the
volumes of all periventricular and deep lesions.
We log transformed the values of total WML, periven-
tricular WML, deep WML and total white matter volume
as they were not normally distributed. We then divided
the log-transformed values into tertiles to allow for non-
linear associations between WML volumes and RLS.
Infarcts were rated on T1-weighted, T2-weighted and
PD-weighted images and deﬁned as focal lesions ≥3m m
in diameter with the same signal characteristic as cere-
brospinal ﬂuid on all sequences. They were discrimi-
nated from dilated Virchow-Robin spaces using
multiplanar reformatting. Those with a typical vascular
shape and following the orientation of perforating
vessels were classiﬁed as dilated Virchow-Robin spaces
and not as infarcts.
30
RLS assessment
RLS was assessed at the ﬁfth and sixth follow-up waves of
the study. Participants were asked series of questions
designed to address the four minimal diagnostic criteria
of the International Restless Legs Study Group which
has been established and validated in previous
studies.
31 32 The participants were asked: “Have you ever
felt unpleasant sensation in the legs (restlessness, tin-
gling, tension, annoyance, annoyances, contractions,
twitching, numbness, electricity, etc) with the irresistible
need or want to move?” Response options were yes or
no. If the participant responded ‘yes’, he or she was
further asked: “Do these unpleasant sensations occur
solely or mainly at rest (when you are sitting or lying
down, without moving your legs) and do they improve
with movement?” and “Are these unpleasant sensations
more intense in the evening or at night than in the
morning?” Response options for these questions were
yes or no. If the participant responded yes to all three
questions, he or she was deﬁned as having RLS.
Covariates
Trained psychologists collected sociodemographic and
medical data on participants during home visits.
Participants were asked if they were treated for various
comorbidities at baseline and in the ﬁfth and sixth waves
of the study. We used all available information from base-
line to RLS assessment to determine a participant’s
comorbidity history. History of cardiovascular disease was
deﬁned as a history of myocardial infarction, stroke,
angina, percutaneous transluminal coronary angioplasty
or coronary artery bypass surgery. History of diabetes was
deﬁned as glycaemia ≥7 mmol/L or use of antidiabetic
treatment.
33 High blood pressure was deﬁned as mea-
sured systolic blood pressure ≥140 mm Hg or measured
diastolic blood pressure ≥90 mm Hg. High cholesterol
was deﬁned as lipid lowering treatment or cholesterol
≥6.2 mmol/L. Information was also collected on history
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history of oedema/swelling of legs and ankles.
For the following covariates, we used values from the
follow-up waves during which RLS was assessed: body
mass index, smoking status, alcohol consumption and
physical activity. If this value was missing, we used values
from baseline. Height and weight were used to calculate
body mass index. Smoking status was reported as never,
past or current, and alcohol consumption was measured
in grams per day. Owing to changes in the question-
naires on physical activity over time, we classiﬁed partici-
pants as active versus non-active.
Statistical analysis
Of the 1924 individuals in the MRI substudy, 1189 were
still alive and participating in the 3C study during the
waves in which RLS was assessed. We excluded 97 partici-
pants who did not answer any of the questions about
RLS and the 57 participants who did not have data on
total WML volume, leaving a total of 1035 participants
eligible for our analyses of which 218 (21.1%) reported
RLS (ﬁgure 1).
We performed a cross-sectional analysis using logistic
regression to calculate ORs and 95% CIs of reporting
RLS for each tertile of WML volume using the lowest
tertile as the reference group. Analyses examining the
association between tertiles of total WML volume and
RLS adjusted for tertiles of total white matter as the like-
lihood of WML correlate with the size of the total white
matter. Analyses examining the association between ter-
tiles of periventricular or deep WML and RLS adjusted
for tertiles of WML. We also used logistic regression to
examine the association between any silent brain infarct
and RLS. For the infarct analyses, we excluded partici-
pants with a brain tumour detected at MRI.
We performed age-adjusted and sex-adjusted analyses
and multivariable-adjusted analyses. Our multivariable
analyses adjusted for age (continuous), sex, smoking
status (never, past or current smoker), alcohol consump-
tion (0, 0 to ≤12, 12 to ≤24 and >24 g/day), physical
activity (active vs not active), body mass index (<25, 25
to <30 and ≥30 kg/m
2), history of hypertension (yes/
no), history of diabetes (yes/no), history of cardiovascu-
lar disease (yes/no), history of peripheral artery disease
(yes/no), history of leg operation (yes/no) and history
of oedema/swelling of legs and ankles (yes/no).
Further adjustment for measures of sleep quality, difﬁ-
culty sleeping and taking sleep medications did not
affect our results (results not shown). All covariates were
measured at baseline. Less than 39 people were missing
information on any covariate, except for quality of sleep
and were assigned to the reference value of that covari-
ate. We created a separate category for those missing
information on quality of sleep. We also performed sep-
arate age-adjusted analyses stratiﬁed by sex or mean age
(72 years).
We considered a two-tailed p value of <0.05 as statistic-
ally signiﬁcant and used SAS V.9.3 as statistical software
(Cary, North Carolina, USA).
RESULTS
The characteristics of the participants by RLS status can be
seen in table 1. Those who reported RLS were more likely
to be women, never-smokers, non-drinkers, and were less
physically active than those who did not report RLS.
We did not observe an association between tertiles of
WML and RLS (table 2). Compared with those in the
lowest tertile of WML, the multivariable-adjusted OR of
reporting RLS was 1.09 (95% CI 0.75 to 1.60) for those
in the second tertile and 1.17 (95% CI 0.79 to 1.74) for
those in the top tertile. We also did not observe an asso-
ciation between tertiles of deep or periventricular WML
and RLS (table 2).
We also performed age-adjusted analyses stratiﬁed by
sex or mean age (72 years). Among men, compared
with those in the lowest tertile of WML, the age-adjusted
OR of reporting RLS was 0.74 (95% CI 0.35 to 1.56) for
those in the second tertile and 0.85 (95% CI 0.41 to
1.77) for those in the top tertile. Among women, com-
pared with those in the lowest tertile of WML, the
age-adjusted OR of reporting RLS was 1.17 (95% CI 0.76
to 1.81) for those in the second tertile and 1.13 (95% CI
0.72 to 1.78) for those in the top tertile. For those
under 72 years of age, the age-adjusted OR of reporting
RLS was 0.99 (95% CI 0.61 to 1.62) for those in the
second tertile and 1.03 (95% CI 0.61 to 1.75) for those
in the top tertile compared with those in the lowest
tertile of WML. For those 72 years of age or older, the
age-adjusted OR of reporting RLS was 1.10 (95% CI 0.61
to 1.98) for those in the second tertile and 1.20 (95% CI
0.68 to 2.10) for those in the top tertile compared with
those in the lowest tertile of WML.
We also explored whether there was an association
between infarcts and RLS. Of the 1031 people with
Figure 1 Flow chart of participants included in this analysis
(RLS, restless legs syndrome; WML, white matter lesions).
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218 reported RLS. The age-adjusted and sex-adjusted
OR between infarcts and RLS was 0.68 (95% CI 0.37 to
1.27). The multivariable-adjusted OR between infarcts
and RLS was 0.78 (95% CI 0.42 to 1.46).
DISCUSSION
In this large, population-based study of elderly indivi-
duals, we found no cross-sectional association between
WML volume or brain infarcts and RLS. The results of
this study do not support an association between RLS
and vascular brain lesions.
Previous research on the association between WML
volume and RLS is limited. A small study of 45 patients
found that white matter hyperintensities were correlated
with total limb movements per hour of sleep after adjust-
ing for hypertension (r=0.66, p=0.01).
34 The authors
suggest that leg movements may be associated with poor
quality sleep which may contribute to episodes of noc-
turnal hypertension. Although nocturnal hypertension
has been associated with the development of white
matter hyperintensities even among those with daytime
hypertension,
35 this study did not present results on the
association between RLS and white matter hyperintensi-
ties. Additionally, it is unclear if the authors adjusted for
other potential confounders including age and sex.
Another study using data from the Memory and
Morbidity in Augsburg Elderly Study (MEMO) examined
the association between RLS and brain lesions detected
using MRI. They found a non-signiﬁcant increase risk of
silent infarction (OR=2.11, 95% CI 0.71 to 6.27) and sub-
cortical brain lesions greater than or equal to 10 mm
(OR=1.35, 95% CI 0.56 to 3.22) in those who reported
RLS compared with those without RLS.
24 The small size
of this study (26 RLS cases and 241 controls) and limited
power to control for confounding by cardiovascular risk
factors may explain some of the differences between the
results of the MEMO study and our study.
While evidence for a direct association between WML
and RLS is limited, some cross-sectional studies have sug-
gested that RLS may be associated with hypertension,
14
stroke
93 6and migraine,
25 26 which are associated with
WML. However, a recent longitudinal study found no
association between RLS and incident cardiovascular
disease
21 and not all cross-sectional studies have found
associations between hypertension and RLS.
91 1Our
study did not ﬁnd an association between RLS and struc-
tural brain lesions which are strongly related to vascular
risk factors and cardiovascular disease. This observation
aligns with the previous study that did not ﬁnd an associ-
ation between RLS and incident cardiovascular disease.
This study has several strengths including the
population-based setting with available brain imaging,
the size of the cohort, and standardised assessment of
RLS using criteria from the International Restless Legs
Study Group.
12We also used an automated measure-
ment procedure to quantify and localise WML.
Compared with visual scale, automated procedures are
not subject to a ceiling effect, permit better discrimin-
ation of lesion volume and are more sensitive in detect-
ing small group differences.
37
Limitations to this study include its cross-sectional
design which prevents us from determining the tem-
poral ordering of RLS and WML or examining how RLS
may impact WML progression over time. RLS was ﬁrst
assessed in the ﬁfth and sixth waves of the study
(approximately 10 years after baseline). Participants who
were still in the study then may be healthier than partici-
pants who died or dropped out prior to RLS assessment.
We did not have information on kidney disease or iron
Table 1 Characteristics of participants by RLS status
Characteristic (%)*
No RLS
(n=817)
RLS
(n=218)
Age (mean, SD) 71.6 (3.9) 71.6 (3.8)
Sex (% female) 59.7 72.9
Smoking status (%)
Never 61.3 67.0
Past 33.5 26.6
Current 5.1 6.4
Alcohol consumption (%)
Non-drinker 18.1 22.0
0t o≤12 g/day 44.6 21.4
12 to ≤24 g/day 19.2 19.3
>24 g/day 15.3 11.5
Physically active (%) 55.9 63.8
Body mass index (kg/m
2)
<25 51.4 56.0
25 to <30 38.8 32.6
≥30 9.8 11.5
History of high blood
pressure (%)
73.3 71.6
History of high cholesterol (%) 58.0 51.4
History of diabetes (%) 13.0 9.2
History of cardiovascular
disease (%)
11.3 7.8
History of stroke (%) 4.5 1.4
History of peripheral artery
disease (%)
2.1 2.8
History of leg operation (%) 0.6 0.5
History of oedema/swelling
of legs and ankles (%)
19.1 25.2
Difficulty sleeping
Never 19.6 14.2
Rarely 52.6 46.8
Regularly 13.1 19.3
Often 12.5 16.5
Quality of sleep
Good 46.9 31.2
Average 30.4 38.5
Mediocre or bad 9.4 13.8
Take medications for sleep 31.2 36.7
Volume of white matter
hyperintensities (cm
3,
median and IQR)
3.9 (2.7–5.8) 4.0 (2.7–6.0)
*Numbers may not add to 100% due to missing data.
RLS, restless legs syndrome.
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Information on RLS was self-reported and potential mis-
classiﬁcation is possible. However, we used the best avail-
able questionnaire for population-level assessment of
RLS and this questionnaire has been validated in previ-
ous cohorts.
31 32 Additionally, our questionnaire did not
assess RLS severity or periodic limb movements associ-
ation with RLS so we are unable to determine if the
severity of RLS or presence of periodic limb movements
may modify the association between RLS and WMH.
While our data do not support a strong association
between structural brain lesions and RLS, further tar-
geted research is warranted to evaluate whether sub-
groups of patients with RLS exist who are at increased
risk for structural brain lesions.
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Table 2 Cross-sectional age-adjusted and sex-adjusted and multivariable-adjusted* associations between RLS and brain
WML volumes
No RLS
(n=817)
RLS
(n=218)
N (%) N (%)
Age-adjusted and sex-adjusted
OR (95% CI)
Multivariable-adjusted*
OR (95% CI)
Total WML volume in tertiles
Lowest tertile 269 (32.9) 73 (33.5) 1.00 1.00
Middle tertile 271 (33.2) 71 (32.6) 1.04 (0.72 to 1.52) 1.09 (0.75 to 1.60)
Highest tertile 277 (33.9) 74 (33.9) 1.09 (0.74 to 1.59) 1.17 (0.79 to 1.74)
Periventricular WML volume in tertiles
Lowest tertile 267 (32.7) 74 (33.9) 1.00 1.00
Middle tertile 273 (33.4) 69 (31.7) 0.86 (0.49 to 1.51) 0.85 (0.48 to 1.50)
Highest tertile 277 (33.9) 75 (34.4) 0.96 (0.44 to 2.10) 0.91 (0.41 to 2.01)
Deep WML volume in tertiles
Lowest tertile 275 (33.7) 66 (30.3) 1.00 1.00
Middle tertile 266 (32.6) 77 (35.3) 1.27 (0.85 to 1.90) 1.24 (0.82 to 1.87)
Highest tertile 276 (33.8) 75 (34.4) 1.27 (0.78 to 2.05) 1.33 (0.81 to 2.17)
*Adjusted for age, sex, smoking status, alcohol consumption, physical activity, body mass index, history of hypertension, history of diabetes,
history of cardiovascular disease, history of peripheral artery disease, history of leg operation and history of oedema/swelling of legs and
ankles.
RLS, restless legs syndrome; WML, white matter lesions.
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